Status:
UNKNOWN
Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control Group
Lead Sponsor:
Clinical Hospital Center, Split
Conditions:
Ulcerative Colitis
Eligibility:
All Genders
18-60 years
Brief Summary
Mucosal inflammation in patients with UC is the result of immunosuppression disturbance because decreasing number of regulatory T ly and activation IL 17
Eligibility Criteria
Inclusion
- endoscopic confirmed diagnosis
Exclusion
- corticosteroid or immunosuppressive therapy
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00805428
Start Date
September 1 2008
Last Update
December 9 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinički bolnički centar Split
Split, Croatia